The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
This paper reviews the literature about first-line therapies for H. pylori infection in recent years. First-line therapies are facing a challenge because of increasing treatment failure due to elevated antibiotics resistance. Several new treatment strategies that recently emerged to overcome antibio...
Saved in:
Main Authors: | Chao-Hung Kuo, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Sophie S. W. Wang, Yen-Hsu Chen, Ming-Chia Hsieh, Ming-Feng Hou, Deng-Chyang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/168361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
by: Meng-Chieh Wu, et al.
Published: (2017-01-01) -
Helicobacter pylori and Systemic Disease
by: Chao-Hung Kuo, et al.
Published: (2014-01-01) -
Helicobacter pylori Infection and Anemia in Taiwanese Adults
by: Hsiang-Yao Shih, et al.
Published: (2013-01-01) -
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
by: Wei-Chen Tai, et al.
Published: (2013-01-01) -
Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies
by: Ju Yup Lee, et al.
Published: (2016-01-01)